Navigation Links
Bill & Melinda Gates Foundation Funds 76 New Ideas to Improve Global Health, From Chewing Gum to Chocolate
Date:10/20/2009

Scientists from 16 countries selected for their unconventional projects to fight infectious diseases

ARUSHA, Tanzania, Oct. 20 /PRNewswire-USNewswire/ -- The Bill & Melinda Gates Foundation today announced 76 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support researchers in 16 countries with ideas as diverse as developing an electronic nose to diagnose tuberculosis and using chocolate to help prevent malaria.

"Some of the biggest stumbling blocks in global health are now being overcome with promising new vaccines and treatments," said Dr. Tachi Yamada, president of the Gates Foundation's Global Health Program. "Grand Challenges Explorations will continue to fill the pipeline with possibilities and hopefully produce a breakthrough idea that could save untold numbers of lives."

In three rounds of the foundation's Grand Challenges Explorations initiative, 262 researchers representing 30 countries have been awarded grants. Newly-funded projects include efforts to develop a paper cup that turns TB-positive sputum samples a bright orange, use a peptide found in scorpions to block development of the malaria parasite, and adapt a protein that parasites use to seal their egg cases as a "sticky coating" for intranasal vaccines.

Grantees from round 3 were selected from almost 3,000 proposals. All levels of scientists are represented - from young post-graduate investigators to veteran researchers - as are a wide range of disciplines, such as chemistry, bioengineering, electronics, mechanical engineering, infectious disease, and epidemiology. They are based at universities, research institutes, nonprofit organizations, and private companies around the world. Examples include:

  • Innovative ways to diagnose infectious diseases:
    • Andrew Fung of University of California, Los Angeles aims to develop chewing gum that can detect malaria biomarkers in saliva;
    • Ranjan Nanda of the International Centre for Genetic Engineering & Biotechnology in India will attempt to create a handheld "electronic nose" that gathers and analyzes breath samples to diagnose tuberculosis;
    • Udantha Abeyratne of the University of Queensland in Australia will equip mobile phones and mp3 players with microphones to record cough and sleep sounds, which could then be screened to diagnose pneumonia.
  • New strategies to fight malaria and mosquitoes:
    • Steven Maranz of Weill Cornell Medical College in New York will test the ability of a compound found in chocolate to keep malaria at bay;
    • Annette Habluetzel of the University of Camerino in Italy will create a micropellet food which, when activated by the sun, could generate toxins that kill mosquito larvae;
    • Peter Lubega Yiga of AdhocWorks Foundation in South Africa will test the efficacy of a fermentation-based household mosquito repellent.
  • More effective vaccines:
    • Cecil Czerkinsky of the International Vaccine Institute in Korea will explore whether vaccines administered under the tongue can produce strong immune responses in distant organs such as the lungs and reproductive tract;
    • Margaret Njoroge of Med Biotech Laboratories in Uganda will develop an intranasal vaccine for mothers, designed to induce antibodies against malaria in breast milk and confer immunity on their babies;
    • Kate Edwards, at the University of San Diego will study how a brief bout of exercise may enhance the efficiency of pneumococcal vaccine.

About Grand Challenges Explorations

Grand Challenges Explorations is a five-year, $100 million initiative to promote innovation in global health. It is part of the Grand Challenges in Global Health initiative, which is supported by the Gates Foundation to achieve major breakthroughs in global health.

Applications for the next round of Grand Challenges Explorations are being accepted through November 2, 2009. Grant application instructions, including the list of topics for which proposals are currently being accepted, are available at http://www.grandchallenges.org/explorations.

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people--especially those with the fewest resources--have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett. Learn more at www.gatesfoundation.org.

For high-resolution still photography and information about the foundation's work, please visit: www.gatesfoundation.org/press-room/Pages/news-market.aspx.

SOURCE Bill & Melinda Gates Foundation


'/>"/>
SOURCE Bill & Melinda Gates Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Guruji Mahendra ... 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... happiness. Mahendra Trivedi is known by over 250,000 people from over 40 different ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence now ... the most minimally invasive approaches. , Women who have had multiple vaginal births ... factors include surgery to the pelvic floor, connective tissue disorders, and obesity. Women ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/5/2016)... ... , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon ... 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped ... Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- HemaFlo Therapeutics, Inc. announced today that the United States Patent ... covering the use of NephroFlow to treat acute kidney injury ... said, "We are pleased to secure our rights to such ... PhD, HemaFlo,s founder, said, "We are pleased to secure our ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ...
(Date:2/8/2016)... , Feb. 8, 2016  Dynatronics Corporation ... of advanced-technology medical devices and rehabilitation equipment for ... congratulates the Denver Broncos, football team for winning ... Cullimore Jr. , Chairman and Chief Executive Officer.  ... and we look forward to enhancing their athletic ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
Breaking Medicine Technology: